• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激活可诱导人B细胞对APO-1(CD95)介导的凋亡产生敏感性。

Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells.

作者信息

Daniel P T, Krammer P H

机构信息

Tumor Immunology Program, German Cancer Research Center, Heidelberg.

出版信息

J Immunol. 1994 Jun 15;152(12):5624-32.

PMID:7515909
Abstract

We have previously described the APO-1 (CD95) cell surface molecule, a novel member of the nerve growth factor/TNF receptor superfamily, identical with the Fas Ag. Triggering of APO-1-induced apoptosis in APO-1+, apoptosis sensitive cells. The data in this study demonstrate that human peripheral blood B cells acquire sensitivity to APO-1-mediated apoptosis on PWM activation. To also study APO-1-mediated apoptosis in an Ag-specific human B cell response, we reconstituted severe combined immunodeficient (SCID) mice i.p. with human PBMC (SCID-hu mice). SCID-hu mice were then injected i.p. with soluble, adjuvant-free tetanus toxoid or diphtheria toxoid, respectively, directly after transfer of the PBMC (day 1) and received an Ag-booster injection on day 14. Two weeks after PBMC transfer human Abs were detected and shown to be Ag specific. SCID-hu mice co-injected with monoclonal anti-APO-1 Ab (IgG3,k) showed significantly suppressed anti-tetanus toxoid or anti-diphtheria toxoid titers, respectively. Sensitivity to anti-APO-1-mediated suppression was only observed in Ag-activated cells from day 0 to day 6 after Ag immunization. Suppression of Ab titers correlated with a decrease of Ag-specific Ig-secreting cells. Re-injection of syngeneic T cells and Ag did not reverse anti-APO-1-induced suppression. These data show a direct suppressive effect of anti-APO-1 on Ag-activated, "specific" B cells. Thus, APO-1-mediated apoptosis in Ag-activated B cells may contribute to the regulation of the humoral immune response.

摘要

我们之前已描述过APO-1(CD95)细胞表面分子,它是神经生长因子/TNF受体超家族的一个新成员,与Fas抗原相同。在APO-1阳性、对凋亡敏感的细胞中,APO-1触发诱导凋亡。本研究中的数据表明,人外周血B细胞在PWM激活后获得对APO-1介导凋亡的敏感性。为了研究在抗原特异性人B细胞应答中APO-1介导的凋亡,我们经腹腔注射人外周血单个核细胞(PBMC)重建重症联合免疫缺陷(SCID)小鼠(SCID-hu小鼠)。然后在PBMC转移后(第1天)立即经腹腔分别给SCID-hu小鼠注射可溶性、无佐剂的破伤风类毒素或白喉类毒素,并在第14天给予抗原加强注射。PBMC转移两周后检测到人类抗体,且显示为抗原特异性的。共同注射单克隆抗APO-1抗体(IgG3,κ)的SCID-hu小鼠分别显示出抗破伤风类毒素或抗白喉类毒素滴度显著受到抑制。仅在抗原免疫后第0天至第6天的抗原激活细胞中观察到对抗APO-1介导抑制的敏感性。抗体滴度的抑制与抗原特异性Ig分泌细胞的减少相关。同基因T细胞和抗原的再次注射并未逆转抗APO-1诱导的抑制。这些数据显示抗APO-1对抗原激活的“特异性”B细胞有直接抑制作用。因此,抗原激活的B细胞中APO-1介导的凋亡可能有助于体液免疫应答的调节。

相似文献

1
Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells.激活可诱导人B细胞对APO-1(CD95)介导的凋亡产生敏感性。
J Immunol. 1994 Jun 15;152(12):5624-32.
2
Specific antibody production to a recall or a neoantigen by SCID mice reconstituted with human peripheral blood lymphocytes.用人外周血淋巴细胞重建的重症联合免疫缺陷(SCID)小鼠对回忆抗原或新抗原产生特异性抗体。
J Immunol. 1993 Oct 1;151(7):3894-901.
3
Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens.抗APO-1类别转换变体单克隆抗体诱导细胞凋亡依赖于APO-1细胞表面抗原的交联。
J Immunol. 1992 Nov 15;149(10):3166-73.
4
Autocrine T-cell suicide mediated by APO-1/(Fas/CD95).由APO-1/(Fas/CD95)介导的自分泌T细胞自杀
Nature. 1995 Feb 2;373(6513):438-41. doi: 10.1038/373438a0.
5
The induction and suppression of in vitro IgG anti-tetanus toxoid antibody synthesis by human lymphocytes stimulated with tetanus toxoid in the absence of in vivo booster immunizations.在无体内加强免疫的情况下,破伤风类毒素刺激人淋巴细胞对体外IgG抗破伤风类毒素抗体合成的诱导与抑制
J Immunol. 1985 Jul;135(1):185-91.
6
The use of the hu-PBL-SCID mouse model to study lymphocyte homing and responsiveness to recall antigens.利用人外周血淋巴细胞-重症联合免疫缺陷(hu-PBL-SCID)小鼠模型研究淋巴细胞归巢及对回忆抗原的反应性。
Reg Immunol. 1992 Mar-Apr;4(2):86-90.
7
Sensitivity of Epstein-Barr virus-induced B cell tumor to apoptosis mediated by anti-CD95/Apo-1/fas antibody.爱泼斯坦-巴尔病毒诱导的B细胞肿瘤对抗CD95/Apo-1/fas抗体介导的细胞凋亡的敏感性。
Eur J Immunol. 1997 Feb;27(2):538-43. doi: 10.1002/eji.1830270227.
8
Regulation of germinal center B cell differentiation. Role of the human APO-1/Fas (CD95) molecule.生发中心B细胞分化的调控。人类APO-1/Fas(CD95)分子的作用。
J Immunol. 1995 Jun 1;154(11):5746-56.
9
Antigen-specific IgG responses from naive human splenocytes: in vitro priming followed by antigen boost in the SCID mouse.来自未经免疫的人类脾细胞的抗原特异性IgG反应:体外致敏后在SCID小鼠中进行抗原增强。
J Immunol. 1998 Mar 1;160(5):2051-8.
10
CD40 stimulation promotes human secondary immunoglobulin responses in HuPBL-SCID chimeras.
Clin Immunol. 1999 Jan;90(1):22-7. doi: 10.1006/clim.1998.4632.

引用本文的文献

1
Dengue Viral Infection Induces Alteration of CD95 Expression in B Cell Subsets with Potential Involvement of Dengue Viral Non-Structural Protein 1.登革病毒感染诱导B细胞亚群中CD95表达的改变,登革病毒非结构蛋白1可能参与其中。
Viruses. 2025 Apr 8;17(4):541. doi: 10.3390/v17040541.
2
Differences in phenotype between long-lived memory B cells against Plasmodium falciparum merozoite antigens and variant surface antigens.长寿命记忆 B 细胞对恶性疟原虫裂殖子抗原和变异表面抗原表型的差异。
PLoS Pathog. 2024 Oct 28;20(10):e1012661. doi: 10.1371/journal.ppat.1012661. eCollection 2024 Oct.
3
Differences in phenotype between long-lived memory B cells against merozoite antigens and variant surface antigens.
针对裂殖子抗原和可变表面抗原的长寿记忆B细胞之间的表型差异。
bioRxiv. 2024 Jun 3:2024.06.01.596978. doi: 10.1101/2024.06.01.596978.
4
IgG-Based Bispecific Anti-CD95 Antibodies for the Treatment of B Cell-Derived Malignancies and Autoimmune Diseases.用于治疗B细胞源性恶性肿瘤和自身免疫性疾病的基于IgG的双特异性抗CD95抗体
Cancers (Basel). 2022 Aug 16;14(16):3941. doi: 10.3390/cancers14163941.
5
An Integrated Multi-omic Single-Cell Atlas of Human B Cell Identity.人类 B 细胞特征的综合多组学单细胞图谱。
Immunity. 2020 Jul 14;53(1):217-232.e5. doi: 10.1016/j.immuni.2020.06.013.
6
A distinct plasmablast and naïve B-cell phenotype in primary immune thrombocytopenia.原发性免疫性血小板减少症中独特的浆母细胞和幼稚B细胞表型。
Haematologica. 2016 Jun;101(6):698-706. doi: 10.3324/haematol.2015.137273. Epub 2016 Mar 11.
7
A Recombinant Bispecific CD20×CD95 Antibody With Superior Activity Against Normal and Malignant B-cells.一种对正常和恶性B细胞具有卓越活性的重组双特异性CD20×CD95抗体。
Mol Ther. 2016 Feb;24(2):298-305. doi: 10.1038/mt.2015.209. Epub 2015 Nov 19.
8
The Fas/CD95 Receptor Regulates the Death of Autoreactive B Cells and the Selection of Antigen-Specific B Cells.Fas/CD95 受体调节自身反应性 B 细胞的死亡和抗原特异性 B 细胞的选择。
Front Immunol. 2012 Jul 25;3:207. doi: 10.3389/fimmu.2012.00207. eCollection 2012.
9
Phase I trial of weekly tigatuzumab, an agonistic humanized monoclonal antibody targeting death receptor 5 (DR5).一项针对死亡受体 5(DR5)的激动型人源化单克隆抗体 tigatuzumab 的每周给药的 I 期临床试验。
Cancer Biother Radiopharm. 2010 Feb;25(1):13-9. doi: 10.1089/cbr.2009.0673.
10
Molecular mechanisms of irradiation-induced apoptosis.辐射诱导凋亡的分子机制
Front Biosci. 2003 Jan 1;8:d9-19. doi: 10.2741/927.